Introducing FIT-Detect+™
Polymedco's next-generation manual fecal immunochemical test is designed to simplify colorectal cancer screening without compromising performance.
FIT-Detect+™ is now available as the replacement for OC-Light S® FIT. Built for flexibility across healthcare settings, from physician offices and labs to at-home use, FIT-Detect+ delivers reliable immunochemical detection with a simplified implementation footprint and minimal disruption to existing screening programs.
Have questions about FIT-Detect+™?
What is FIT-Detect+™?
FIT-Detect+™ is a rapid, qualitative fecal immunochemical test (FIT) that detects human hemoglobin in stool samples, providing an important early indicator of gastrointestinal conditions including colorectal cancer, polyps, colitis, and diverticulitis. Using solid-phase chromatographic immunoassay technology, FIT-Detect+ is specific to human hemoglobin and unaffected by animal hemoglobin from food sources, eliminating the need for dietary restrictions before testing. Recommended annually by the American Cancer Society for average-risk adults age 45 and older, FIT-Detect+ is designed for use across a wide range of healthcare settings, including physician offices, clinical labs, and direct-to-patient programs.1
Important Transition Notice
OC-Light S® FIT will be discontinued and FIT-Detect+™ is the designated successor. Polymedco is committed to a seamless transition; contact your representative to begin planning today.
key features
Built for Simplicity. Designed for Performance.
Single-sample collection
One sample is all it takes, reducing patient burden and simplifying program logistics.
No analyzer required
FIT-Detect+ is a lateral flow immunochemical test. No specialized instrumentation or laboratory analyzer needed.
Easy-to-use cassette format
Clear positive/negative result interpretation in 5–10 minutes, suitable for professional testing or patient self-collection.
At-home screening option
Supports direct-to-patient distribution models, helping extend screening reach beyond the clinical setting and improve program participation rates.
No dietary or medication restrictions
Patients do not need to modify their diet or pause medications before testing, removing a common barrier to compliance.
Cost-effective screening solution
Analyzer-free workflow and simplified collection process support efficient, scalable implementation across healthcare settings.
Validation Data
Current validation data demonstrate2:
- Detection limit of 50 µg Hb/g feces (50 ng hHb/mL buffer)
- 100% agreement with expected results across all tested concentrations in laboratory comparison studies
- 99.7% agreement with expected results across 300 samples in three-site physician office laboratory (POL) studies
- High reproducibility across test lots
Disclaimer
Current data reflects analytical validation studies. Results are not conclusive evidence of the presence or absence of gastrointestinal disease. Any positive result should be followed up with further clinical examination.
Frequently Asked Questions
What is FIT-Detect+™?
FIT-Detect+ is a manual fecal immunochemical test (FIT) designed to detect hidden blood (humanhemoglobin) in stool samples as an aid in identifying gastrointestinal disorders, including colorectal cancer.
Why is Polymedco making this change?
FIT-Detect+ was selected to provide a simpler patient experience while maintaining strong clinical performance and supporting cost-effective colorectal cancer screening programs.
Does FIT-Detect+ require specialized laboratory equipment?
No. FIT-Detect+ is a simple lateral flow immunochemical test that does not require an analyzer or specialized instrumentation.
Can patients complete the test at home?
Yes. FIT-Detect+™ supports at-home sample collection, making it well-suited for direct mail and direct-to-patient distribution programs. The personal use kit is a complete, self-contained collection package. Samples are stable at room temperature for up to 10 days, providing flexibility for return logistics.
Does FIT-Detect+ require a single sample or multiple samples?
FIT-Detect+™ uses a single-sample collection process, reducing patient burden and simplifying the overall screening workflow.
Are there dietary or medication restrictions before testing?
No. Patients do not need to modify their diet or discontinue medications prior to testing. FIT-Detect+ is specific to human hemoglobin and does not cross-react with animal hemoglobin from common food sources.
How does FIT-Detect+ compare to OC-Light S?
FIT-Detect+™ offers reliable FIT screening performance with the added benefit of an improved cassette format, single-sample collection, and the option for at-home patient use. Polymedco will provide detailed transition support to help your organization maintain continuity in the screening program.
Will our screening program need to change significantly?
Most organizations should experience minimal disruption during the transition. Because FIT-Detect+ does not require an analyzer, labs and physician offices that relied on OC-Light S for strip-based FIT will find the workflows compatible. Polymedco will work closely with your team to support implementation, training, and ordering logistics.
Will ordering information change?
Yes. FIT-Detect+ will have new product SKUs and ordering information that will replace the current OC-Light S SKUs. Polymedco will provide detailed guides and ordering resources to help customers identify the appropriate replacement products and ensure an easy transition.
When should we begin planning our transition?
We encourage customers to begin planning now. OC-Light S® FIT will be discontinued effective September 2026, with the transition period spanning Q3 and early Q4 2026. Beginning the conversation early ensures the smoothest possible changeover for your program and patients.
Will training and support be available?
Yes. Polymedco will provide educational materials, implementation guidance, and hands-on support resources throughout the transition. Your Polymedco representative is your primary point of contact for transition planning.
Will pricing change with FIT-Detect+?
Polymedco is committed to making this process as smooth as possible for customers. Pricing for FIT-Detect+ is expected to remain comparable to current OC-Light S pricing.
Is FIT-Detect+ cost-effective?
Yes. The analyzer-free workflow, simplified patient collection process, and single-sample design are intended to support cost-effective implementation across a range of healthcare settings, from large health systems to independent physician offices.
Where can I find the Instructions for Use (IFU)?
Ready to Transition?
From evaluating implementation timelines to aligning ordering and training with your program's operational needs, our team is here to support your move to FIT-Detect+™.
Contact your Polymedco representative or reach us at customer_service@polymedco.com.